» Articles » PMID: 37331435

Collagen VI Deposition Mediates Stromal T Cell Trapping Through Inhibition of T Cell Motility in the Prostate Tumor Microenvironment

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2023 Jun 18
PMID 37331435
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor extracellular matrix (ECM) is a barrier to anti-tumor immunity in solid tumors by disrupting T cell-tumor cell interaction underlying the need for elucidating mechanisms by which specific ECM proteins impact T cell motility and activity within the desmoplastic stroma of solid tumors. Here, we show that Collagen VI (Col VI) deposition correlates with stromal T cell density in human prostate cancer specimens. Furthermore, motility of CD4+ T cells is completely ablated on purified Col VI surfaces when compared with Fibronectin and Collagen I. Importantly, T cells adhered to Col VI surfaces displayed reduced cell spreading and fibrillar actin, indicating a reduction in traction force generation accompanied by a decrease in integrin β1 clustering. We found that CD4+ T cells largely lack expression of integrin α1 in the prostate tumor microenvironment and that blockade of α1β1 integrin heterodimers inhibited CD8+ T cell motility on prostate fibroblast-derived matrix, while re-expression of ITGA1 improved motility. Taken together, we show that the Col VI-rich microenvironment in prostate cancer reduces the motility of CD4+ T cells lacking integrin α1, leading to their accumulation in the stroma, thus putatively inhibiting anti-tumor T cell responses.

Citing Articles

Collagen-disruptive cell therapy: adoptive transfer of membrane-anchored, tumor cell surface vimentin-targeted interleukin 12-armed TILs suppress collagen expression to boost deep T-cell infiltration via dual signaling activation and significant....

Li S Res Sq. 2024; .

PMID: 39574893 PMC: 11581118. DOI: 10.21203/rs.3.rs-5104493/v1.


The spatial distribution of intermediate fibroblasts and myeloid-derived cells dictate lymph node metastasis dynamics in oral cancer.

Shaikh S, Dhar H, Moorthy M, Bhat V, Basu S, Banerjee D J Transl Med. 2024; 22(1):759.

PMID: 39138492 PMC: 11323585. DOI: 10.1186/s12967-024-05511-1.


Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy.

Hong Y, Lv Z, Xing Z, Xu H, Chand H, Wang J Front Pharmacol. 2024; 15:1325447.

PMID: 38375034 PMC: 10875022. DOI: 10.3389/fphar.2024.1325447.


Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.

Testa A, Quaglia F, Naranjo N, Verrillo C, Shields C, Lin S Matrix Biol. 2023; 124:49-62.

PMID: 37956856 PMC: 10823877. DOI: 10.1016/j.matbio.2023.11.003.